Letter to the Editor

Politico – January 19, 2017

Drs. Kenar Jhaveri and Richard Barnett, from the Feinstein Institute for Medical Research, write in the New England Journal of Medicine about a drug combination that may help prevent rejection of a donor kidney in transplant patients undergoing cancer treatment by allowing immune checkpoint inhibitors to be incorporated into a patient’s treatment regimen.